SpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG Test
25 sept. 2018 08h00 HE
|
SpeeDx Pty Ltd
SYDNEY, Australia, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. today announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG (not...